Inventaire - your friends and communities are your best library

Ranibizumab: in diabetic macular oedema

published in: tuberculosis

date of publication: 2012-03-01

Cites articles 25

Date

Title

Authors

2011-04-01

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema

Ursula Schmidt-Erfurth, Christian Simader, Francesco Bandello, Reinier O Schlingemann
2011-04-01

Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

Diabetic Retinopathy Clinical Research Network, Adam R Glassman, Ingrid U. Scott, Neil M. Bressler, Roy W. Beck
2011-06-01

Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation

Diabetic Retinopathy Clinical Research Network, Adam R Glassman, Neil M. Bressler, Susan B Bressler, Roy W. Beck
2011-09-14

Ranibizumab in the treatment of patients with visual impairment due to diabetic macular edema

Karl Anders Knutsson, Francesco Bandello
2010-11-01

Current approaches to the management of diabetic retinopathy and diabetic macular oedema
2010-07-01

Burden of illness of diabetic macular edema: literature review

Darius Lakdawalla
2010-01-15

Optimal current and future treatments for diabetic macular oedema
2010-11-01

Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study

Simon P. Harding, Michael Larsen, Sebastian Wolf, Francesco Bandello
2010-10-01

Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy.

Napoleone Ferrara
2010-09-19

Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study

Thomas A Ciulla
2010-04-28

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

Diabetic Retinopathy Clinical Research Network, Adam R Glassman, Kellee M Miller, Ingrid U. Scott
2010-06-26

Diabetic retinopathy
2009-08-22

Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study
2009-01-22

The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes

Ronald E Gangnon, Ronald Klein
2009-10-01

Short-term fluctuation of diabetic macular edema after intravitreal ranibizumab injection

Giuseppe Querques, Domenico Martinelli
2008-11-01

Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab
2007-01-01

Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema
2007-01-03

The North Jutland County Diabetic Retinopathy Study (NCDRS) 2. Non-ophthalmic parameters and clinically significant macular oedema

Søren Lundbye-Christensen
2007-01-01

Ranibizumab.

Antona J Wagstaff, Gillian M Keating
2007-06-13

Ranibizumab inhibits multiple forms of biologically active vascular endothelial growth factor in vitro and in vivo

Mauricio Maia
2006-10-01

Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration

Napoleone Ferrara
2006-08-02

Vascular endothelial growth factor is a critical stimulus for diabetic macular edema
2006-10-01

A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema
1985-12-01

Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group
1984-05-01

Macular edema. A complication of diabetic retinopathy

Article - wd:Q34166795

Welcome to Inventaire

the library of your friends and communities

learn more